FR2814957B1 - Composition vaccinale et procede de stabilisation - Google Patents

Composition vaccinale et procede de stabilisation

Info

Publication number
FR2814957B1
FR2814957B1 FR0012805A FR0012805A FR2814957B1 FR 2814957 B1 FR2814957 B1 FR 2814957B1 FR 0012805 A FR0012805 A FR 0012805A FR 0012805 A FR0012805 A FR 0012805A FR 2814957 B1 FR2814957 B1 FR 2814957B1
Authority
FR
France
Prior art keywords
vaccine composition
stabilization method
stabilization
vaccine
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0012805A
Other languages
English (en)
Other versions
FR2814957A1 (fr
Inventor
Alain Francon
Catherine Noel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0012805A priority Critical patent/FR2814957B1/fr
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Priority to CA002424863A priority patent/CA2424863A1/fr
Priority to PCT/FR2001/003097 priority patent/WO2002028362A2/fr
Priority to KR1020037004927A priority patent/KR100832551B1/ko
Priority to US10/381,948 priority patent/US6982088B2/en
Priority to AU9567201A priority patent/AU9567201A/xx
Priority to MXPA03002875A priority patent/MXPA03002875A/es
Priority to EP01976379A priority patent/EP1357895A2/fr
Priority to NZ525117A priority patent/NZ525117A/en
Priority to AU2001295672A priority patent/AU2001295672B2/en
Priority to JP2002531988A priority patent/JP2004526667A/ja
Priority to BR0114350-6A priority patent/BR0114350A/pt
Priority to CNB018169708A priority patent/CN1298387C/zh
Publication of FR2814957A1 publication Critical patent/FR2814957A1/fr
Application granted granted Critical
Publication of FR2814957B1 publication Critical patent/FR2814957B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR0012805A 2000-10-06 2000-10-06 Composition vaccinale et procede de stabilisation Expired - Fee Related FR2814957B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0012805A FR2814957B1 (fr) 2000-10-06 2000-10-06 Composition vaccinale et procede de stabilisation
JP2002531988A JP2004526667A (ja) 2000-10-06 2001-10-08 ワクチン組成物および安定化方法
KR1020037004927A KR100832551B1 (ko) 2000-10-06 2001-10-08 백신 조성물 및 안정화 방법
US10/381,948 US6982088B2 (en) 2000-10-06 2001-10-08 Vaccine composition and stabilization method using high molecular weight PVP
AU9567201A AU9567201A (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method
MXPA03002875A MXPA03002875A (es) 2000-10-06 2001-10-08 Composicion de vacuna y metodo de estabilizacion.
CA002424863A CA2424863A1 (fr) 2000-10-06 2001-10-08 Composition vaccinale et procede de stabilisation
NZ525117A NZ525117A (en) 2000-10-06 2001-10-08 Vaccine composition stabilised by addition of high-molecular-weight polyvinylpyrrolidone, in particular PVF360 whose molecular weight is 360 000 daltons
AU2001295672A AU2001295672B2 (en) 2000-10-06 2001-10-08 Vaccine composition and stabilisation method
PCT/FR2001/003097 WO2002028362A2 (fr) 2000-10-06 2001-10-08 Composition vaccinale et procede de stabilisation
BR0114350-6A BR0114350A (pt) 2000-10-06 2001-10-08 Composição vacinal e processo de estabilização da mesma no estado lìquido
CNB018169708A CN1298387C (zh) 2000-10-06 2001-10-08 疫苗组合物和稳定化的方法
EP01976379A EP1357895A2 (fr) 2000-10-06 2001-10-08 Composition vaccinale et procede de stabilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0012805A FR2814957B1 (fr) 2000-10-06 2000-10-06 Composition vaccinale et procede de stabilisation

Publications (2)

Publication Number Publication Date
FR2814957A1 FR2814957A1 (fr) 2002-04-12
FR2814957B1 true FR2814957B1 (fr) 2002-12-20

Family

ID=8855080

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0012805A Expired - Fee Related FR2814957B1 (fr) 2000-10-06 2000-10-06 Composition vaccinale et procede de stabilisation

Country Status (12)

Country Link
US (1) US6982088B2 (fr)
EP (1) EP1357895A2 (fr)
JP (1) JP2004526667A (fr)
KR (1) KR100832551B1 (fr)
CN (1) CN1298387C (fr)
AU (2) AU9567201A (fr)
BR (1) BR0114350A (fr)
CA (1) CA2424863A1 (fr)
FR (1) FR2814957B1 (fr)
MX (1) MXPA03002875A (fr)
NZ (1) NZ525117A (fr)
WO (1) WO2002028362A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5138601B2 (ja) * 2005-11-21 2013-02-06 サノフィ パストゥール リミテッド 組換えウイルス安定化製剤
WO2012028315A1 (fr) * 2010-09-02 2012-03-08 Sanofi Pasteur Sa Agent stabilisant pour la préparation d'une composition de vaccin contre la poliomyélite, injectable, sèche
IL312872A (en) 2011-06-28 2024-07-01 Inhibrx Inc Methods for purifying fusion proteins containing serphin
MX356433B (es) 2011-06-28 2018-05-29 Inhibrx Lp Polipéptidos de fusión con domino de proteína ácida del suero, y métodos de uso de los mismos.
US10400029B2 (en) 2011-06-28 2019-09-03 Inhibrx, Lp Serpin fusion polypeptides and methods of use thereof
JP6253161B2 (ja) * 2012-03-05 2017-12-27 デ スタート デル ネーデルランデン， ヴェルト． ドール デ ミニステル ヴァン ヴイダブリューエス ミニステリー ヴァン ボルクスゲツォントヘイト， ベルジーン エン シュポルトＤｅ Ｓｔａａｔ Ｄｅｒ Ｎｅｄｅｒｌａｎｄｅｎ， Ｖｅｒｔ． Ｄｏｏｒ Ｄｅ Ｍｉｎｉｓｔｅｒ Ｖａｎ Ｖｗｓ Ｍｉｎｉｓｔｅｒｉｅ Ｖａｎ Ｖｏｌｋｓｇｅｚｏｎｄｈｅｉｄ， Ｗｅｌｚｉｊｎ Ｅｎ Ｓｐｏｒｔ 乾燥された生物学的材料を安定化するための方法及び組成物
EP2968515B1 (fr) * 2013-03-14 2019-05-08 Takeda Vaccines, Inc. Compositions et procédés pour formulations d'alphavirus atténué vivant
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
US20210322542A1 (en) * 2020-04-11 2021-10-21 Qiyi Xie Vaccination against coronavirus with poliomyelitis vaccine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617350C3 (de) * 1967-06-22 1979-09-06 Behringwerke Ag, 3550 Marburg Verfahren zur Inaktivierung von biologischem Material
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US3915764A (en) * 1973-05-18 1975-10-28 Westinghouse Electric Corp Sputtering method for growth of thin uniform layers of epitaxial semiconductive materials doped with impurities
ATE60999T1 (de) * 1986-12-19 1991-03-15 Duphar Int Res Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension.
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
AU2088992A (en) * 1992-05-05 1993-11-11 Research Foundation For Microbial Diseases Of Osaka University, The Stabilized live vaccine
WO1994015636A1 (fr) * 1993-01-08 1994-07-21 Csl Limited Preparations de vaccins
AU7971194A (en) * 1993-10-12 1995-05-04 Chiron Corporation Methods for preserving recombinant viruses
US6379677B1 (en) * 2000-02-25 2002-04-30 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Streptococcus iniae vaccine

Also Published As

Publication number Publication date
WO2002028362A2 (fr) 2002-04-11
CA2424863A1 (fr) 2002-04-11
CN1468091A (zh) 2004-01-14
NZ525117A (en) 2006-08-31
EP1357895A2 (fr) 2003-11-05
US6982088B2 (en) 2006-01-03
WO2002028362A3 (fr) 2003-09-12
AU2001295672B2 (en) 2005-08-18
JP2004526667A (ja) 2004-09-02
BR0114350A (pt) 2004-02-17
KR100832551B1 (ko) 2008-05-26
CN1298387C (zh) 2007-02-07
US20030190331A1 (en) 2003-10-09
FR2814957A1 (fr) 2002-04-12
MXPA03002875A (es) 2003-07-14
AU9567201A (en) 2002-04-15
KR20030096223A (ko) 2003-12-24

Similar Documents

Publication Publication Date Title
DE60127333D1 (de) Wirbelsäulenimplantat
AR028279A1 (es) Dispositivo para estabilizacion de segmentos de hueso
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20013536L (no) Sammensetninger og fremgangsmåter for mukosal levering
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
FR2815535B1 (fr) Implant pediculaire
DE60135103D1 (de) Endoskopische stabilisierungsvorrichtung
FR2803504B1 (fr) Oreiller anatomique
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
DE60120276D1 (de) Laserbehandlungsgerät
DE60105229D1 (de) Laserbehandlungsgerät
DK1220849T3 (da) Sammensætninger med bicykliske forbindelser og fremgangsmåde til stabilisering heraf
DE60121531D1 (de) Laserbehandlungsgerät
DE60100737D1 (de) Laserbehandlungsgerät
NO20032614D0 (no) Farmasöytisk sammensetning med forbedret absorbabilitet
FR2814957B1 (fr) Composition vaccinale et procede de stabilisation
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
ITMI20011503A0 (it) Procedimeno per sterilizzare oggetti
DE60138593D1 (de) Verzerrungsausgleichverfahren und Gerät
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
AU2001295672A1 (en) Vaccine composition and stabilisation method
ITMI20011533A0 (it) Procedimento e dispositivo per comandare svolgimenti di esercizio
ID28764A (id) Metode penstabilan senyawa n-oksil dalam senyawa vinil

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20090630